Brickell Biotech Inc reports results for the quarter ended in March - Earnings Summary

Fresh Tracks Therapeutics

14/05/2021 01:47

* Brickell Biotech Inc  BBI.OQ  reported a quarterly adjusted
loss of 15 cents​​ per share for the quarter ended in March. The
mean expectation of two analysts for the quarter was for a loss
of 11 cents per share.
* Revenue was $17.00 thousand​;  analysts expected $50.00
thousand. 
* Brickell Biotech Inc's reported EPS for the quarter was a loss
of 15 cents​.
* The mean earnings estimate of analysts had fallen by about 15%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Brickell Biotech Inc shares had fallen by 20.2% this
quarter and gained 11.5% so far this year.
* The company reported a quarterly loss of $9.01 million.
* Wall Street's median 12-month price target for Brickell
Biotech Inc is $5.50 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated May 14 at 12:47 a.m. GMT.
​All figures in US dollars